Chemomab Therapeutics Ltd...
(CMMB)
undefined
undefined%
At close: undefined
1.60
0.63%
After-hours Dec 13, 2024, 05:42 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY12 |
Cash & Equivalents | 9.29M | 13.52M | 14.69M | 11.67M | 17.58M | 7.52M | 1.45M | 4.56M | 2.21M | 5.72M |
Short-Term Investments | 10.49M | 26.37M | 46.48M | 24.00K | - | - | - | - | 151.12K | - |
Long-Term Investments | - | - | 55.00K | 4.00K | 130.00K | 120.00K | - | - | - | - |
Other Long-Term Assets | 559.00K | 733.00K | 908.00K | 53.00K | 57.00K | 1.34M | 279.00K | 567.73K | 241.84K | 174.00K |
Receivables | 289.00K | - | 179.00K | 74.00K | 636.00K | 3.40M | 88.00K | 139.01K | 129.78K | 192.17K |
Inventory | - | - | -47.50M | -657.00K | -542 | -77.00K | - | 1.00 | - | - |
Other Current Assets | 824.00K | 1.84M | 1.35M | 67.00K | 542.00K | 2.62M | 47.00K | 169.15K | 607.55K | 3.60M |
Total Current Assets | 20.90M | 41.74M | 62.69M | 11.84M | 18.21M | 10.92M | 1.59M | 4.87M | 3.10M | 9.16M |
Property-Plant & Equipment | 695.00K | 594.00K | 702.00K | 580.00K | 1.36M | 385.00K | 219.00K | 213.32K | 176.30K | 153.00K |
Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - |
Total Long-Term Assets | 1.25M | 1.33M | 1.67M | 637.00K | 1.54M | 1.84M | 498.00K | 781.05K | 418.14K | 327.00K |
Total Assets | 22.15M | 43.06M | 64.35M | 12.48M | 19.76M | 12.76M | 2.09M | 5.65M | 3.52M | 9.48M |
Account Payables | 516.00K | 1.69M | 1.34M | 93.00K | 25.00K | 396.00K | 160.00K | 106.53K | 589.56K | 761.00K |
Deferred Revenue | - | - | - | - | 2.00 | - | - | - | - | - |
Short-Term Debt | 76.00K | 123.00K | 106.00K | 70.00K | 478.00K | - | - | - | - | - |
Other Current Liabilities | 4.25M | 4.59M | 1.21M | 1.15M | 3.62M | 2.35M | 2.54M | 2.25M | 743.24K | 4.13M |
Total Current Liabilities | 4.84M | 6.75M | 2.65M | 1.32M | 4.12M | 2.75M | 2.70M | 2.36M | 1.33M | 4.89M |
Long-Term Debt | 316.00K | 91.00K | 237.00K | 358.00K | 108.00K | - | - | - | - | - |
Other Long-Term Liabilities | - | - | - | - | 617.00K | 210.00K | - | - | 37.78K | 1.30M |
Total Long-Term Liabilities | 316.00K | 91.00K | 237.00K | 358.00K | 725.00K | 210.00K | - | - | 37.78K | 1.30M |
Total Liabilities | 5.15M | 6.84M | 2.89M | 1.67M | 4.85M | 2.96M | 2.70M | 2.36M | 1.37M | 6.19M |
Total Debt | 392.00K | 214.00K | 343.00K | 428.00K | 1.12M | - | - | - | - | - |
Common Stock | - | - | - | - | - | - | 2.77M | 1.92M | 1.26M | 922.00K |
Retained Earnings | -88.68M | -63.82M | -36.17M | -23.70M | -105.43M | -78.31M | -62.88M | -52.70M | -47.46M | -112.75M |
Comprehensive Income | - | -0.00 | 0.00 | 872.00K | 872.00K | 4.44M | 2.22M | 1.32M | 1.07M | - |
Shareholders Equity | 17.00M | 36.22M | 61.47M | 10.80M | 14.91M | 9.80M | -609.00K | 3.29M | 2.14M | 3.29M |
Total Investments | 10.49M | 26.37M | 46.48M | 28.00K | 130.00K | 120.00K | - | - | 151.12K | - |